In a digital age where every biotech startup aggressively markets its IP and clinical trials, Arrevus.com stands out by aggressively not existing. With a $1.1M valuation and a team of just 7, this is a company operating in stealth mode—or perhaps, in stasis.

"Their website gets zero traffic. Their Twitter redirects to a completely different domain. This isn't a marketing strategy; it's a digital ghost town."

The leadership team consists of Carl Kraus (Founder and CEO) and Laszlo Otvos (Scientific Advisor). With such a small team and no visible product pipeline or press releases, the company appears to be a holding vehicle for intellectual property or a research project that hasn't yet sought public visibility.

• Revenue of $1.1M with only 7 employees suggests high efficiency or niche services.
• Tech stack is modern (Tailwind, Bootstrap) but content is nonexistent.
• Social media presence is broken; Twitter link leads to a dead redirect.
• No backlinks or organic keywords detected—complete SEO blackout.